Sign In
25 May 2022 15:41
GSK Plc - Director/PDMR ShareholdingGSK Plc - Director/PDMR Shareholding
PR Newswire
London, May 25
GSK plc (the ‘Company’)
Transaction notification
| 1. | Details of PDMR/person closely associated with them (‘PCA’) | ||||
| a) | Name | Dr H Barron | |||
| b) | Position/status | Chief Scientific Officer and President, R&D | |||
| c) | Initial notification/ amendment | Initial notification | |||
| 2. | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | ||||
| a) | Name | GSK plc | |||
| b) | LEI | 5493000HZTVUYLO1D793 | |||
| 3. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted | ||||
| a) | Description of the financial instrument | American Depositary Shares (‘ADSs’) ISIN: US37733W1053 | |||
| b) | Nature of the transaction | Acquisition of notional ADSs within Dr Barron’s GSK Executive Supplemental Savings Plan account. | |||
| c) | Price(s) and volume(s) | Price(s) | Volume(s) | ||
| $44.7500 | 1,151.020 | ||||
| d) | Aggregated information | N/A (single transaction) | |||
| Aggregated volume Price | |||||
| e) | Date of the transaction | 2022-05-23 | |||
| f) | Place of the transaction | New York Stock Exchange (XNYS) | |||
Glaxosmithkline (GSK)
Follow the stocks
